Page last updated: 2024-08-22

nootkatone and Dyslipidemias

nootkatone has been researched along with Dyslipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Al Ahbabi, MM; Azimullah, S; Goyal, SN; Jha, NK; Lakshmanan, VK; Meeran, MFN; Ojha, S	1

Other Studies

1 other study(ies) available for nootkatone and Dyslipidemias

Article	Year
Nootkatone, a Dietary Fragrant Bioactive Compound, Attenuates Dyslipidemia and Intramyocardial Lipid Accumulation and Favorably Alters Lipid Metabolism in a Rat Model of Myocardial Injury: An In Vivo and In Vitro Study. Molecules (Basel, Switzerland), 2020, Nov-30, Volume: 25, Issue:23 Topics: Animals; Antioxidants; Cardiotonic Agents; Dyslipidemias; Lipid Peroxidation; Lipids; Male; Myocardial Infarction; Oxidative Stress; Polycyclic Sesquiterpenes; Rats; Rats, Wistar	2020

Article

Year

Nootkatone, a Dietary Fragrant Bioactive Compound, Attenuates Dyslipidemia and Intramyocardial Lipid Accumulation and Favorably Alters Lipid Metabolism in a Rat Model of Myocardial Injury: An In Vivo and In Vitro Study.

Molecules (Basel, Switzerland), 2020, Nov-30, Volume: 25, Issue:23

Topics: Animals; Antioxidants; Cardiotonic Agents; Dyslipidemias; Lipid Peroxidation; Lipids; Male; Myocardial Infarction; Oxidative Stress; Polycyclic Sesquiterpenes; Rats; Rats, Wistar

2020